Using anticoagulants safely. Guidelines for therapeutic and prophylactic regimens

Area of Science:

• Cardiology
• Hematology
• Vascular Medicine

Background:

• Heparin and warfarin sodium are primary treatments for thromboembolic and arterial diseases.
• These anticoagulants, along with other agents, prevent deep venous thrombosis and pulmonary embolism in high-risk patients.

Purpose of the Study:

• To review the therapeutic applications of heparin and warfarin sodium.
• To highlight their role in preventing venous thromboembolism in at-risk populations.
• To emphasize the importance of monitoring anticoagulation therapy.

Main Methods:

• Literature review of established anticoagulation therapies.
• Discussion of clinical indications for heparin and warfarin sodium.
• Overview of monitoring parameters for anticoagulation.

Main Results:

• Heparin and warfarin sodium are widely used for acute and recurrent venous thromboembolic disease, arterial disease, valvular heart disease, and atrial fibrillation.
• Combined with other interventions, they are crucial for preventing deep venous thrombosis and pulmonary embolism in high-risk individuals.
• Therapeutic ranges for activated partial thromboplastin time and prothrombin time are essential for effective anticoagulation.

Conclusions:

• Heparin and warfarin sodium are indispensable in managing and preventing thromboembolic events.
• Effective anticoagulation relies on appropriate patient selection and vigilant monitoring.
• Multimodal approaches enhance the prevention of deep venous thrombosis and pulmonary embolism.